tiprankstipranks
Trending News
More News >
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (PL:SVE)
:SVE
Poland Market

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (SVE) Cash flow

Compare
0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Cash Flow

PL:SVE's free cash flow for Q3 2025 was zł-20.66M. For the 2025 fiscal year, PL:SVE's free cash flow was decreased by zł89.83M and operating cash flow was zł-15.84M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
zł 13.73Mzł -5.34Mzł 2.95Mzł -3.28Mzł 343.00K
Investing Cash Flow
zł -25.89Mzł -72.90Mzł -26.97Mzł -4.49Mzł -2.02M
Financing Cash Flow
zł 10.75Mzł 53.33Mzł 36.82Mzł 20.22Mzł 2.86M
End Cash Position
zł 760.00Kzł 2.17Mzł 27.09Mzł 14.30Mzł 1.84M
Free Cash Flow
zł -28.11Mzł -117.95Mzł -33.81Mzł -21.71Mzł -1.68M
Currency in PLN

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Cash Flow